TCAP knockdown by RNA interference inhibits myoblast differentiation in cultured skeletal muscle cells

Neuromuscular Disorders

Volumn 18, Issue 5, 2008, Pages 413-422

  Markert, Chad D ^a   Ning, Jie ^b   Staley, Jerry T ^c   Heinzke, Laura ^b   Childers, Charles K ^a   Ferreira, J Andries ^b   Brown, Marybeth ^c,d   Stoker, Aaron ^b   Okamura, Carol ^b   Childers, Martin K ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c University of Missouri   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

Author keywords

Muscular dystrophy; Myogenic regulatory factors; Telethonin

Indexed keywords

MESSENGER RNA; MYOGENIC FACTOR; PROTEIN; TITIN CAP PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HYPOTHESIS; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STATISTICAL SIGNIFICANCE;

ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; INSULIN-LIKE GROWTH FACTOR II; MICE; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MYOBLASTS, SKELETAL; MYOD PROTEIN; MYOGENIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 43449135295     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2008.03.010     Document Type: Article

References (40)

1. Faulkner G., Pallavicini A., Comelli A., Salamon M., Bortoletto G., Ievolella C., et al. FATZ, a filamin-, actinin-, and telethonin-binding protein of the Z-disc of skeletal muscle. J Biol Chem 275 52 (2000) 41234-41242
2. Mason P., Bayol S., and Loughna P.T. The novel sarcomeric protein telethonin exhibits developmental and functional regulation. Biochem Biophys Res Commun 257 3 (1999) 699-703
3. Wang J., Shaner N., Mittal B., Zhou Q., Chen J., Sanger J.M., et al. Dynamics of Z-band based proteins in developing skeletal muscle cells. Cell Motil Cytoskeleton 61 1 (2005) 34-48
4. Mayans O., van d V., Wilm M., Mues A., Young P., Furst D.O., et al. Structural basis for activation of the titin kinase domain during myofibrillogenesis. Nature 395 6705 (1998) 863-869
5. Mues A., van d V., Young P., Furst D.O., and Gautel M. Two immunoglobulin-like domains of the Z-disc portion of titin interact in a conformation-dependent way with telethonin. FEBS Lett 428 1-2 (1998) 111-114
6. Furukawa T., Ono Y., Tsuchiya H., Katayama Y., Bang M.L., Labeit D., et al. Specific interaction of the potassium channel beta-subunit minK with the sarcomeric protein T-cap suggests a T-tubule-myofibril linking system. J Mol Biol 313 4 (2001) 775-784
7. Valle G., Faulkner G., De A.A., Pacchioni B., Pallavicini A., Pandolfo D., et al. Telethonin, a novel sarcomeric protein of heart and skeletal muscle. FEBS Lett 415 2 (1997) 163-168
8. Gregorio C.C., Trombitas K., Centner T., Kolmerer B., Stier G., Kunke K., et al. The NH2 terminus of titin spans the Z-disc: its interaction with a novel 19-kDa ligand (T-cap) is required for sarcomeric integrity. J Cell Biol 143 4 (1998) 1013-1027
9. Moreira E.S., Wiltshire T.J., Faulkner G., Nilforoushan A., Vainzof M., Suzuki O.T., et al. Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat Genet 24 2 (2000) 163-166
10. Bos J.M., Poley R.N., Ny M., Tester D.J., Xu X., Vatta M., et al. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. Mol Genet Metab 88 1 (2006) 78-85
11. Hayashi T., Arimura T., Itoh-Satoh M., Ueda K., Hohda S., Inagaki N., et al. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J Am Coll Cardiol 44 11 (2004) 2192-2201
12. Nicholas G., Thomas M., Langley B., Somers W., Patel K., Kemp C.F., et al. Titin-cap associates with, and regulates secretion of, myostatin. J Cell Physiol 193 1 (2002) 120-131
13. Joulia D., Bernardi H., Garandel V., Rabenoelina F., Vernus B., and Cabello G. Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp Cell Res 286 2 (2003) 263-275
14. 12 myogenesis. Biochem Biophys Res Commun 280 2 (2001) 561-566
15. 12 muscle cells. Am J Physiol Endocrinol Metab 280 2 (2001) E221-E228
16. Thomas M., Langley B., Berry C., Sharma M., Kirk S., Bass J., et al. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 275 51 (2000) 40235-40243
17. Langley B., Thomas M., Bishop A., Sharma M., Gilmour S., and Kambadur R. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 277 51 (2002) 49831-49840
18. Rios R., Carneiro I., Arce V.M., and Devesa J. Myostatin is an inhibitor of myogenic differentiation. Am J Physiol Cell Physiol 282 5 (2002) C993-C999
19. McPherron A.C., Lawler A.M., and Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387 6628 (1997) 83-90
20. Ohsawa Y., Hagiwara H., Nakatani M., Yasue A., Moriyama K., Murakami T., et al. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition. J Clin Invest 116 11 (2006) 2924-2934
21. Haworth R.S., Cuello F., Herron T.J., Franzen G., Kentish J.C., Gautel M., et al. Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function. Circ Res 95 11 (2004) 1091-1099
22. Kojic S., Medeot E., Guccione E., Krmac H., Zara I., Martinelli V., et al. The Ankrd2 protein, a link between the sarcomere and the nucleus in skeletal muscle. J Mol Biol 339 2 (2004) 313-325
23. Tian L.F., Li H.Y., Jin B.F., Pan X., Man J.H., Zhang P.J., et al. MDM2 interacts with and downregulates a sarcomeric protein, TCAP. Biochem Biophys Res Commun 345 1 (2006) 355-361
24. Coletti D., Yang E., Marazzi G., and Sassoon D. TNFalpha inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways. EMBO J 21 4 (2002) 631-642
25. Whither. RNAi?. Nat Cell Biol 5 6 (2003) 489-490
26. van der G.K., Di-Marco S., Clair E., and Gallouzi I.E. RNAi-mediated HuR depletion leads to the inhibition of muscle cell differentiation. J Biol Chem 278 47 (2003) 47119-47128
27. Pfaffl M.W., Horgan G.W., and Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30 9 (2002) e36
28. Lee S.J. Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol 20 (2004) 61-86
29. Engel F.B., Hauck L., Boehm M., Nabel E.G., Dietz R., and von H.R. p21(CIP1) Controls proliferating cell nuclear antigen level in adult cardiomyocytes. Mol Cell Biol 23 2 (2003) 555-565
30. Curran-Everett D., and Benos D.J. Guidelines for reporting statistics in journals published by the American Physiological Society. Physiol Genomics 18 3 (2004) 249-251
31. Engvall E., and Wewer U.M. The new frontier in muscular dystrophy research: booster genes. FASEB J 17 12 (2003) 1579-1584
32. Pescatori M., Broccolini A., Minetti C., Bertini E., Bruno C., D'amico A., et al. Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. FASEB J 21 4 (2007) 1210-1212
33. Kocamis H., Gahr S.A., Batelli L., Hubbs A.F., and Killefer J. IGF-I, IGF-II, and IGF-receptor-1 transcript and IGF-II protein expression in myostatin knockout mice tissues. Muscle Nerve 26 1 (2002) 55-63
34. Lalani R., Bhasin S., Byhower F., Tarnuzzer R., Grant M., Shen R., et al. Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight. J Endocrinol 167 3 (2000) 417-428
35. Wilson E.M., and Rotwein P. Control of MyoD function during initiation of muscle differentiation by an autocrine signaling pathway activated by insulin-like growth factor-II. J Biol Chem 281 40 (2006) 29962-29971
36. Svoboda P. Off-targeting and other non-specific effects of RNAi experiments in mammalian cells. Curr Opin Mol Ther 9 3 (2007) 248-257
37. Kim D.H., Longo M., Han Y., Lundberg P., Cantin E., and Rossi J.J. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat Biotechnol 22 3 (2004) 321-325
38. Kwon Y.W., Kwon K.S., Moon H.E., Park J.A., Choi K.S., Kim Y.S., et al. Insulin-like growth factor-II regulates the expression of vascular endothelial growth factor by the human keratinocyte cell line HaCaT. J Invest Dermatol 123 1 (2004) 152-158
39. Amali A.A., Lin C.J., Chen Y.H., Wang W.L., Gong H.Y., Lee C.Y., et al. Up-regulation of muscle-specific transcription factors during embryonic somitogenesis of zebrafish (Danio rerio) by knock-down of myostatin-1. Dev Dyn 229 4 (2004) 847-856
40. Di C.A., De M.R., Martelli F., Pompilio G., Capogrossi M.C., and Germani A. Hypoxia inhibits myogenic differentiation through accelerated MyoD degradation. J Biol Chem 279 16 (2004) 16332-16338